Europe Pharmaceutical Excipients Market, By Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, and Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) – Industry Trends and Forecast to 2030.
Europe Pharmaceutical Excipients Market Analysis and Size
Pharmaceutical excipients play a major role in drug formulation and its development. These substances involve substances other than the pharmacologically active drug or prodrug. Pharmaceutical excipients provide the drug with efficient drug delivery to the target site. These molecules prevent the drug from being released too early while assimilation and enhancing the drug efficacy. Some pharmaceutical excipients promote drug integration which boosts drug absorption in the bloodstream. Pharmaceutical excipients can act as binders, fillers, diluents, suspension or coating agents, flavoring agents, disintegrants, colorants, lubricants and glidants, sweeteners, and preservatives, among others. Pharmaceutical excipients possess several functionalities used for different purposes, including binders and adhesives, disintegrants, solubilizers, flavors, emulsifying agents, preservatives, antioxidants, glidients, and chelating agents, among others.
Data Bridge Market Research analyses that the Europe pharmaceutical excipients market which was USD 2,172.05 million in 2022, is expected to reach USD 4,586.83 million by 2030, and is expected to undergo a CAGR of 6.3% during the forecast period of 2023 to 2030. “Binders and Adhesives” segment dominates the functionality segment of the Europe pharmaceutical excipients market owing to the advancements in technology have led to the development of advancements pharmaceutical excipients for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Pharmaceutical Excipients Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, and Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) |
|
Countries Covered |
Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe |
|
Market Players Covered |
Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany), Omya AG (Switzerland), Peter Greven GmbH & Co. KG (Germany), Ashland (U.S.), Evonik (Germany), Dow (U.S.), Croda International Plc (United Kingdom), Roquette Frères (France), The Lubrizol Corporation (U.S.), BASF SE (Germany), Avantor, Inc. (U.S.), BENEO (Germany), Chemie Trade (U.S.) |
|
Market Opportunities |
|
Market Definition
Pharmaceutical excipients play a major role in drug formulation and its development. These substances involve substances other than the pharmacologically active drug or prodrug. Pharmaceutical excipients provide the drug with efficient drug delivery to the target site. These molecules prevent the drug from being released too early while assimilation and enhancing the drug efficacy. Some pharmaceutical excipients promote drug integration which boosts drug absorption in the bloodstream.
Europe Pharmaceutical Excipients Market Dynamics
Drivers
- Growing Pharmaceutical Industry
The pharmaceutical sector in Europe is expanding due to increasing healthcare demands and aging populations. This growth drives the demand for pharmaceutical excipients to formulate new drugs and enhance existing formulations.
- Advancements in Drug Formulation
Pharmaceutical excipients play a vital role in improving drug stability, solubility, and bioavailability. Continuous advancements in drug formulation techniques and excipient functionalities boost market growth.
- Advancements in Biopharmaceuticals and Biosimilars
The development of biopharmaceuticals and biosimilars requires specialized excipients. As these sectors expand, the demand for excipients tailored for them grows.
Opportunities
- Bioavailability Enhancement
Innovations in excipient technology are focusing on improving the bioavailability of poorly soluble drugs. Excipients that enhance solubility and dissolution rates offer significant opportunities.
- Customized Excipients
Tailored excipients that meet specific formulation needs are in demand. Companies offering customization services have a competitive advantage.
Restraints/Challenges
- Price Volatility
The prices of certain excipients can be volatile due to factors like raw material costs and supply chain disruptions. Price fluctuations can affect profit margins.
- Regulatory Challenges
Meeting regulatory requirements can be complex and time-consuming. New excipients may face delays in approval processes.
This Europe pharmaceutical excipients market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe pharmaceutical excipients market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2022, Kerry Group Plc., the world’s leading taste and nutrition company, announced that it had made two significant biotechnology acquisitions that have expanded its expertise, technology portfolio, and manufacturing capabilities. The company has announced that it has acquired the leading biotechnology innovation company, c-LEcta, and Mexican-based enzyme manufacturer, Enmex. c-LEcta is a leading biotechnology innovation company specializing in precision fermentation, optimized bio-processing, and bio-transformation. Also, Enmex is a well-established enzyme manufacturer based in Mexico, supplying multiple bio-process solutions for food, beverage, and animal nutrition markets. This has helped company to increase its revenue
- In September 2022, DFE Pharma, a Europe leader in pharma- and nutraceutical excipient solutions, opened its new “Closer to the Formulator” (C2F), a Center of Excellence, in Hyderabad, India. C2F helped pharmaceutical companies to shorten the time from concept to finished commercial product through its expertise in all phases of pharmaceutical development. This has helped the company to showcase its progress
Europe Pharmaceutical Excipients Market Scope
Europe pharmaceutical excipients market is segmented into functionality, dosage forms, route of administration, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Functionality
- Binders and Adhesives
- Disintegrants
- Coating Material
- Coloring Agents
- Solubilizers
- Flavors
- Sweetening Agents
- Diluents
- Lubricants
- Buffers
- Emulsifying Agents
- Preservatives
- Antioxidants
- Sorbents
- Solvents
- Emollients
- Glidents
- Chelating Agents
- Antifoaming Agents
- Others
Dosage Form
- Solid
- Semi-Solid
- Liquid
Route of Administration
- Oral Excipients
- Topical Excipients
- Parenteral Excipients
- Other Excipients
End user
- Pharmaceutical and Biopharmaceutical Companies
- Contract Formulators
- Research Organization and Academics
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Europe Pharmaceutical Excipients Market Regional Analysis/Insights
The Europe pharmaceutical excipients market is analyzed, and market size information is provided functionality, dosage forms, and route of administration, end-user, and distribution channel.
The countries covered in the Europe pharmaceutical excipients market report are Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, and Rest of Europe.
Germany is dominating in the Europe pharmaceutical excipients market due to the presence of key market players in the largest consumer market with high GDP and is also expected to grow fastest in the Europe pharmaceutical excipients market due to the rise in technological advancement in Healthcare IT.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Europe pharmaceutical excipients market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe pharmaceutical excipients market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Europe pharmaceutical excipients market. The data is available for historic period 2015-2020.
Competitive Landscape and Europe Pharmaceutical Excipients Market Share Analysis
The Europe pharmaceutical excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe pharmaceutical excipients market.
Some of the major players operating in the Europe Pharmaceutical Excipients Market are:
- Kerry Group plc. (Ireland)
- DFE Pharma (Netherlands)
- Cargill, Incorporated (U.S.)
- Pfanstiehl (U.S.)
- Colorcon (U.S.)
- MEGGLE GmbH & Co. KG (Germany)
- Omya AG (Switzerland)
- Peter Greven GmbH & Co. KG (Germany)
- Ashland (U.S.)
- Evonik (Germany)
- Dow (U.S.)
- Croda International Plc (United Kingdom)
- Roquette Frères (France)
- The Lubrizol Corporation (U.S.)
- BASF SE (Germany)
- Avantor, Inc. (U.S.)
- BENEO (Germany)
- Chemie Trade (U.S.)
SKU-
